Spread of Dermatophytes Among Families
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2004 by University Hospitals of Cleveland.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
University Hospitals of Cleveland
Collaborator:
Novartis
Information provided by:
University Hospitals of Cleveland
ClinicalTrials.gov Identifier:
NCT00233493
First received: October 3, 2005
Last updated: NA
Last verified: November 2004
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective is to demonstrate person-to-person spread of dermatophytes of the skin and nails among family members, as measured by fungal culture and DNA typing of the dermatophytes isolated.
| Condition |
|---|
|
Onychomycosis Tinea Pedis |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Prospective |
| Official Title: | Demonstration of the Spread of Dermatophytes Through Casual Contact Among Family Household Members |
Resource links provided by NLM:
Further study details as provided by University Hospitals of Cleveland:
| Estimated Enrollment: | 150 |
| Study Start Date: | March 2005 |
| Estimated Study Completion Date: | February 2006 |
Enrolled families consist of at least two members over the age of 14. Once the index person is examined and a dermatophyte is isolated from either toenail or foot scale, other family members are examined and cultured. All dermatophyte isolates obtained from each family unit are compared using DNA typing and restriction length polymorphism (RFLP) to determine whether family members share the same organism or were infected by an outside source.
Eligibility| Ages Eligible for Study: | 14 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria: positive dermatophyte culture
-
Exclusion Criteria:
- use of antifungal agents, either oral or topical
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00233493
Contacts
| Contact: Mahmoud A Ghannoum, PhD | 216-844-8580 | mag3@case.edu |
| Contact: Nancy Isham, BA | 216-983-3093 | nancy.isham@uhhs.com |
Locations
| United States, Ohio | |
| Neil Korman, MD | Recruiting |
| Cleveland, Ohio, United States, 44106 | |
| Contact: ZsaZsa Hann 216-844-5899 zsazsa.hann@uhhs.com | |
Sponsors and Collaborators
University Hospitals of Cleveland
Novartis
Investigators
| Principal Investigator: | Mahmoud A Ghannoum, PhD | Center for Medical Mycology, University Hosp. of Cleveland |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00233493 History of Changes |
| Other Study ID Numbers: | CSFO327KUS16 |
| Study First Received: | October 3, 2005 |
| Last Updated: | October 3, 2005 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University Hospitals of Cleveland:
|
dermatophytes |
Additional relevant MeSH terms:
|
Tinea Tinea Pedis Onychomycosis Dermatomycoses Skin Diseases, Infectious Infection Mycoses |
Skin Diseases Foot Dermatoses Foot Diseases Pruritus Skin Manifestations Signs and Symptoms Nail Diseases |
ClinicalTrials.gov processed this record on May 22, 2013